Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,281 | 113 | 96.4% |
| Education | $84.99 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $695.62 | 35 | $0 (2023) |
| Exeltis, USA Inc. | $207.30 | 11 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $145.04 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $126.73 | 7 | $0 (2023) |
| Aspira Women's Health Inc | $120.62 | 6 | $0 (2024) |
| Organon LLC | $117.17 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $109.36 | 2 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $101.79 | 4 | $0 (2024) |
| TherapeuticsMD, Inc. | $98.40 | 5 | $0 (2021) |
| Lupin Inc. | $86.40 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $490.69 | 18 | Astellas Pharma US Inc ($109.36) |
| 2023 | $279.61 | 13 | Sumitomo Pharma America, Inc. ($52.93) |
| 2022 | $263.32 | 12 | Exeltis, USA Inc. ($66.19) |
| 2021 | $509.97 | 28 | AbbVie Inc. ($310.63) |
| 2020 | $456.11 | 27 | AbbVie Inc. ($141.42) |
| 2019 | $334.56 | 14 | AbbVie, Inc. ($170.11) |
| 2018 | $18.27 | 1 | Merck Sharp & Dohme Corporation ($18.27) |
| 2017 | $13.05 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($13.05) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.49 | General |
| 11/14/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: OB/GYN | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/22/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Hematology | ||||||
| 07/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Hematology | ||||||
| 07/20/2024 | Applied Medical Resources Corporation | — | Food and Beverage | In-kind items and services | $45.86 | General |
| 07/17/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Biological | ||||||
| 05/17/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: HORMONE THERAPY | ||||||
| 05/15/2024 | Becton, Dickinson and Company | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Surgery | ||||||
| 03/21/2024 | Baxter Healthcare | PERCLOT (Device) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: Surgical Care | ||||||
| 03/05/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: OB/GYN | ||||||
| 02/08/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: HORMONE THERAPY | ||||||
| 01/31/2024 | Exeltis, USA Inc. | NUVESSA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ANTIBIOTIC | ||||||
| 01/25/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 01/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: HORMONE THERAPY | ||||||
| 10/17/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: HORMONE THERAPY | ||||||
| 09/20/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $24.88 | General |
| 08/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Womens Health | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: ETONOGESTREL | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: ETONOGESTREL | ||||||
| 08/02/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Hematology | ||||||
| 07/25/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 54 | 55 | $10,578 | $3,733 |
| 2021 | 2 | 31 | 40 | $8,118 | $3,333 |
| 2020 | 3 | 38 | 43 | $4,071 | $1,687 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 21 | $5,727 | $1,766 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $3,441 | $1,274 | 37.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 16 | 16 | $1,410 | $693.04 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 19 | $4,602 | $1,834 | 39.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 21 | $3,517 | $1,499 | 42.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 18 | $2,946 | $1,128 | 38.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 12 | 12 | $1,046 | $530.27 | 50.7% |
| 81003 | Automated urinalysis test | Office | 2020 | 11 | 13 | $79.56 | $29.05 | 36.5% |
About Dr. Cassidy Sullivan, M.D
Dr. Cassidy Sullivan, M.D is a Obstetrics & Gynecology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1821483900.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cassidy Sullivan, M.D has received a total of $2,366 in payments from pharmaceutical and medical device companies, with $490.69 received in 2024. These payments were reported across 114 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,281).
As a Medicare-enrolled provider, Sullivan has provided services to 123 Medicare beneficiaries, totaling 138 services with total Medicare billing of $8,754. Data is available for 3 years (2020–2022), covering 8 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Long Beach, CA
- Active Since 04/05/2015
- Last Updated 08/15/2019
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821483900
Products in Payments
- LO LOESTRIN FE (Drug) $200.16
- ORIAHNN (Drug) $186.89
- SLYND (Drug) $180.04
- Orilissa (Drug) $170.11
- MYFEMBREE (Drug) $166.53
- NEXPLANON (Drug) $161.65
- OVA1 (Device) $120.62
- ACCRUFER (Drug) $101.79
- ORILISSA (Drug) $90.09
- SOLOSEC (Drug) $86.40
- Kyleena (Drug) $86.14
- LILETTA (Drug) $60.45
- ANNOVERA (Drug) $58.23
- Minerva ES (Device) $44.89
- ZURZUVAE (Drug) $44.12
- Mirena (Drug) $40.59
- PERCLOT (Device) $39.00
- INTERSTIM (Device) $37.88
- UBRELVY (Drug) $29.04
- DERMABOND (Device) $26.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Long Beach
Ha Nguyen, M.d, M.D
Obstetrics & Gynecology — Payments: $8,782
Helen Yang
Obstetrics & Gynecology — Payments: $7,665
Patrick Mcmanus, Md, MD
Obstetrics & Gynecology — Payments: $7,373
Dr. Neel Iyer, Do, DO
Obstetrics & Gynecology — Payments: $6,555
Dr. Jocelyn Craig, M.d, M.D
Obstetrics & Gynecology — Payments: $6,190
Briana Livingston
Obstetrics & Gynecology — Payments: $6,084